Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer
Open Access
- 17 November 2009
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (1), 35-41
- https://doi.org/10.1038/sj.bjc.6605427
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Review of Current Evidence-Based Clinical Applications for Breast Magnetic Resonance ImagingTopics in Magnetic Resonance Imaging, 2008
- Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancerAnnals of Oncology, 2008
- Recommendations on the Use of 18F-FDG PET in OncologyJournal of Nuclear Medicine, 2008
- Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancerBritish Journal of Cancer, 2008
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaJournal of Clinical Oncology, 2007
- Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27Journal of Clinical Oncology, 2006
- Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant ChemotherapyAnnals of Surgery, 2006
- Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast CancerAmerican Journal of Roentgenology, 2005
- Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancerEuropean Journal of Surgical Oncology, 2004
- Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imagingCancer, 1996